(Q41001278)

English

Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report

scientific article published on January 1960

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 September 2017

Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report (English)

1 reference

Europe PubMed Central

25 September 2017

author name string

ALVING AS

1

1 reference

Europe PubMed Central

25 September 2017

JOHNSON CF

2

1 reference

Europe PubMed Central

25 September 2017

TARLOV AR

3

1 reference

Europe PubMed Central

25 September 2017

BREWER GJ

4

1 reference

Europe PubMed Central

25 September 2017

KELLERMEYER RW

5

1 reference

Europe PubMed Central

25 September 2017

CARSON PE

6

1 reference

Europe PubMed Central

25 September 2017

language of work or name

0 references

publication date

1 January 1960

1 reference

Europe PubMed Central

25 September 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

Bulletin of the World Health Organization

1 reference

Europe PubMed Central

25 September 2017

22

1 reference

Europe PubMed Central

25 September 2017

621-631

1 reference

Europe PubMed Central

25 September 2017

Erythrocyte glucose-6-phosphate dehydrogenase deficiency: evidence of differences between Negroes and Caucasians with respect to this genetically determined trait

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2555355

25 September 2017

Malaria research and eradication in the USSR. A review of Soviet achievements in the field of malariology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2555355

25 September 2017

An hereditary enzymatic defect in erythrocyte metabolism: glucose-6-phosphage dehydrogenase deficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2555355

25 September 2017

Enzymatic deficiency in primaquine-sensitive erythrocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2555355

25 September 2017

Korean vivax malaria. II. Curative treatment with pamaquine and primaquine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2555355

25 September 2017

Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2555355

15 June 2018

Toxicity of primaquine in Negroes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2555355

19 August 2018

Mass therapy of subclinical vivax malaria with primaquine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2555355

19 August 2018

The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (Panama, P-F-6 strain).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2555355

19 August 2018

The effect of continuous and intermittent primaquine therapy on the relapse rate of Chesson strain vivax malaria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2555355

19 August 2018

Mass antimalarial therapy in veterans returning from Korea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2555355

19 August 2018

Studies in human malaria. XXXI. Comparison of primaquine, isopentaquine, SN-3883, and pamaquine as curative agents against Chesson strain vivax malaria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2555355

19 August 2018

Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2555355

1 October 2018

Studies on glutathione stability in erythrocytes of cases with past history of favism or sulfa-drug-induced hemolysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/13793053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A genetic study of a defect in glutathione metabolism of the erythrocyte

1 reference

https://pubmed.ncbi.nlm.nih.gov/13793053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical and genetic aspects of primaquine-sensitive hemolytic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/13793053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzymatic Abnormality in Erythrocytes of a Population Sensitive to Vicia Faba Or Hæmolytic Anæmia Induced by Drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/13793053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[New aspects of the biochemical alterations in the erythrocytes of patients with favism; almost complete absence of glucose-6-phosphate dehydrogenase.]

1 reference

https://pubmed.ncbi.nlm.nih.gov/13793053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hemolytic effect of primaquine. VIII. The effect of drug administration on parameters of primaquine sensitivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/13793053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A deficiency of glucose-6-phosphate dehydrogenase activity in erythrocytes from patients with favism

1 reference

https://pubmed.ncbi.nlm.nih.gov/13793053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective occurrence of glutathione instability in red blood corpuscles of the various Jewish tribes

1 reference

https://pubmed.ncbi.nlm.nih.gov/13793053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The bio-enzymatic individuality of the fabic erythrocytes; some biochemical & enzymatic anomalies of erythrocytes in patients affected with favism & members of their family.]

1 reference

https://pubmed.ncbi.nlm.nih.gov/13793053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic abnormalities of erythrocytes from patients with congenital nonspherocytic hemolytic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/13793053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hemolytic effect of primaquine. IX. Enzymatic abnormalities in primaquine-sensitive erythrocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/13793053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hemolytic effect of primaquine. V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/13793053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hemolytic effect of primaquine. VII. Biochemical studies of drug-sensitive erythrocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/13793053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemolytic anemia induced by sulfoxone therapy, with investigations into the mechanisms of its production

1 reference

https://pubmed.ncbi.nlm.nih.gov/13793053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hemolytic effect of primaquine. X. Aldolase and glyceraldehyde-3-phosphate dehydrogenase activity in primaquine-sensitive erythrocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/13793053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose-6-Phosphate Dehydrogenase and Human Erythrocytes: Characteristics of Glucose-6-Phosphate Dehydrogenase from Normal and Primaquine-sensitive Erythrocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/13793053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzymatic metabolism of drugs and other foreign compounds

1 reference

https://pubmed.ncbi.nlm.nih.gov/13793053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hemolytic effect of primaquine. III. A study of primaquine-sensitive erythrocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/13793053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hemolytic effect of primaquine. I. The localization of the drug-induced hemolytic defect in primaquine-sensitive individuals.

1 reference

https://pubmed.ncbi.nlm.nih.gov/13793053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

25 September 2017

1 reference

Europe PubMed Central

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41001278&oldid=2092936018"